Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-06 @ 7:38 AM
Study NCT ID:
NCT05417594
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2022-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Malignancies | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Ovarian cancer | View |
| None | Fallopian tube cancer | View |
| None | Prostate cancer | View |
| None | Poly ADP-ribose Polymerase inhibitor (PARPi) | View |
| None | Anti-tumour | View |
| None | Breast cancer | View |
| None | Pancreatic cancer | View |
| None | Soft tissue disease | View |
| None | Glioma | View |
| None | Astrocytoma | View |
| None | Oliogodendroglioma | View |
| None | Solid tumours | View |